An observational study to determine the efficacy of FOGSI gestosis score as a predictor of pre-eclampsia and Ecosprin prophylaxis as a preventive intervention
DOI:
https://doi.org/10.18203/2320-6012.ijrms20253170Keywords:
Ecosprin, Gestosis score, Prediction, PreeclampsiaAbstract
Background: FOGSI gestosis score is a simple risk model devised for preeclampsia screening and prediction. Each risk factor is given score of 1, 2 or 3 based on severity. A total score of ≥3, implies ‘at risk’ for developing preeclampsia warranting closer monitoring and management. Also, Ecosprin prophylaxis in these high-risk pregnancies can reduce the incidence of early onset preeclampsia as well as maternal and neonatal morbidity and mortality.
Methods: This prospective OBSERVATIONAL study was conducted at GMC Amritsar, involving 100 pregnant women at ≤24 weeks of gestation (Group A), screened using gestosis score. Participants identified as high-risk (score ≥3) received prophylactic Ecosprin and monitored until 6 weeks postpartum for maternal and neonatal outcomes which were compared with 145 unbooked, already known cases of preeclampsia/eclampsia (group B).
Results: Among 100 participants screened as per gestosis score, 29% were high risk and 71% low risk. Preeclampsia developed in 31% of high-risk versus 4.2% of low-risk participants (IRR=8.98, p=0.0002). Significant predictors included anaemia, primigravida status, BMI>30 and MAP>85 mmHg. Preterm birth, FGR, unfavourable APGAR score and perinatal mortality were more common in the high-risk group. The score demonstrated 82.35% sensitivity, 82.69% specificity, 43.75% PPV, 96.63% NPV, and 82.64% accuracy in predicting Preeclampsia, indicating good screening potential.
Conclusions: Gestosis score is low cost, noninvasive screening tool for predicting preeclampsia and adverse pregnancy outcomes, particularly in resource-constrained settings. Early Ecosprin prophylaxis significantly reduces the incidence and severity of complications in high-risk pregnancies.
Metrics
References
Dhinwa M, Gawande K, Jha N, Anjali M, Bhadoria AS, Sinha S. Prevalence of hypertensive disorders of pregnancy in India: a systematic review and meta-analysis. J Med Evid. 2021;2(2):105-12. DOI: https://doi.org/10.4103/JME.JME_168_20
Nobis PN, Hajong A. Eclampsia in India through the decades. J Obstet Gynaecol India. 2016;66(Suppl.1):172-6. DOI: https://doi.org/10.1007/s13224-015-0807-5
World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: World Health Organization; 2011.
Tranquilli AL, Brown MA, Zeeman GG, Dekker G, Sibai BM. The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Pregnancy Hypertens. 2013;3(1):44-7. DOI: https://doi.org/10.1016/j.preghy.2012.11.001
Subki AH, Algethami MR, Baabdullah WM, Alnefaie MN, Alzanbagi MA, Alsolami RM, et al. Prevalence, risk factors, and fetal and maternal outcomes of hypertensive disorders of pregnancy: a retrospective study in Western Saudi Arabia. Oman Med J. 2018;33(5):409. DOI: https://doi.org/10.5001/omj.2018.75
Mishra SS, Mohanty S, Ghadei R, Pradhan S, Majhi PP. HDP gestosis score as a Predictor of PIH. Int J Sci Res. 2020;9(8):25-8.
Pahwa S, Kakkar S. A retrospective observational study on HDP gestosis score as a predictor of PIH. N Indian J OBGYN. 2020;22(8):325-34.
Sravani R, Reddy GP. HDP gestosis score as a predictor of pregnancy induced hypertension (PIH). Int J Clin Obstet Gynaecol. 2022;6(5):1-4. DOI: https://doi.org/10.33545/gynae.2022.v6.i5a.1207
Gupta M, Yadav P, Yaqoob F. A prospective study to determine the predictive ability of HDP-gestosis score for the development of pre-eclampsia. J Obstet Gynecol India. 2022;72(6):485-91. DOI: https://doi.org/10.1007/s13224-022-01704-0
Imam ST. Improvement in the cases of hypertensive disorder of pregnancy with help of HDP-gestosis score. Int J Reprod Contracept Obstet Gynecol. 2023;12:671-4. DOI: https://doi.org/10.18203/2320-1770.ijrcog20230536
Vajreswari A, Penumaka RM, Paidisirisha. Prediction of preeclampsia by HDP gestosis score. IOSR J Dent Med Sci. 2023;22(2):27-32.
Sachdeva P, Jain M, Ahmed N. Retrospective study to estimate gestosis score in high-risk pregnant women and its clinical correlation. Int J Life Sci Biotech Pharma Res. 2023;12(2):957-61.
Surovi FA, Noor S, Ali SI, Mabud FN, Ferdoues J, Yeashmin M. Role of aspirin in pregnancy with high gestosis score and outcome. Chattagram Maa-O-Shishu Hosp Med Coll J. 2024;23(1):78-83. DOI: https://doi.org/10.3329/cmoshmcj.v23i1.78455
Upadhyay A, Chaurasia A. Prediction of preeclampsia by HDP gestosis score. Int J Reprod Contracept Obstet Gynecol. 2024;13(7):1726-30. DOI: https://doi.org/10.18203/2320-1770.ijrcog20241766
Vingh S, Aditya V, Ankita. Evaluation of the HDP gestosis score for predicting preeclampsia in the first trimester of pregnancy. Int J Adv Res. 2024;13(4):311-27. DOI: https://doi.org/10.21474/IJAR01/20722
Reddy P, Indrani C, Vydyanath V. A prospective study to determine the predictive ability of hypertensive disorders during pregnancy-gestosis score for the development of pre-eclampsia. Int J Reprod Contracept Obstet Gynecol. 2024;13:1-7. DOI: https://doi.org/10.18203/2320-1770.ijrcog20242989
Amrutiya SD, Kaila PM, Koradia TM, Patel YA. Application of HDP gestosis score for predicting pregnancy-induced hypertension in first trimester antenatal patients at a tertiary care center. Int J Toxicol Pharmacol Res. 2024;15(1):7-11.
Kharodia SA, Kshirsagar NS, Patil S. Prediction of pre-eclampsia using gestosis score. Bioinformation. 2024;20(10):1390-5. DOI: https://doi.org/10.6026/9732063002001390
Ebrashy A, Ibrahim M, Marzook A, Yousef D. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J. 2005;46(5):826-31.
Downloads
Published
How to Cite
Issue
Section
